BRIEF-Auxilium expects to submit supplemental biologics license application for Xiaflex to FDA in Q1

Mon Nov 18, 2013 7:26am EST

Nov 18 (Reuters) - Auxilium Pharmaceuticals Inc : * Announces results of the xiaflex in dupuytren's multicord contracture trial * Says expects to submit supplemental biologics license application to FDA in

Q1 of 2014 on xiaflex * Source text for Eikon * Further company coverage

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article